Active Trials
Working with researchers at Baylor Scott & White Health and institutions around the globe, our physicians, surgeons and advanced practice providers oversee a wide selection of clinical trials.
Filter:
Study Name: CLASP IID/IIF
Study Title: Edwards PASCAL TrAnScatheter Mitral Valve RePair System Pivotal Clinical Trial (CLASP IID)
Sponsor: Edwards Lifesciences
PI: Szerlip/Smith Ii
Therapeutic Group: Vascular
Study Name: CLASP II TR
Study Title: Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP II TR): A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation
Sponsor: Edwards Lifesciences
PI: Smith Ii
Therapeutic Group: Heart Failure
Study Name: APX-115
Study Title: Effect on Contrast Induced Acute Kidney Injury of APX-115 in Subjects undergoing Percutaneous Coronary Intervention (APX-115)
Sponsor: Aptabio Therapeutics Inc.
PI: Thomas
Therapeutic Group: Pulmonary Hypertension
Study Name: REDEFINE 4
Study Title: Efficacy and safety of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema s.c. 2.4 mg/2.4 mg) once-weekly compared to tirzepatide 15 mg s.c. once-weekly in participants with obesity
Sponsor: Novo Nordisk A/S
PI: Hollander
Therapeutic Group: Electrophysiology
Study Name: REDEFINE 1
Study Title: Efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) once-weekly in participants with overweight or obesity
Sponsor: Novo Nordisk A/S
PI: Hollander
Therapeutic Group: Cardiology
Study Name: EMPOWER CAD
Study Title: Equity in Modifying Plaque of Women with Undertreated Calcified Coronary Artery Disease
Sponsor: Shockwave Medical, Inc.
PI: Szerlip
Therapeutic Group: Heart Failure
Study Name: Esprit BTK
Study Title: Esprit BTK Post-Approval Study
Sponsor: Abbott Medical Devices
PI: Kane
Therapeutic Group: Vascular
Study Name: SAFE-LEADS
Study Title: Evaluating the Safety and Diagnostic Utility of Cardiac MRI in Patients with Abandoned, Fractured Endocardial Leads or Permanent Epicardial Leads
Sponsor: CVRRC
PI: Wang
Therapeutic Group: Vascular
Study Name: AV Imaging Study
Study Title: Evaluation Of Preoperative Imaging For Patients With Aortic Insufficiency And Planned Aortic Valve Repair Surgery
Sponsor: CVRRC
PI: Brinkman
Therapeutic Group: Cardiology
Study Name: ARISE II
Study Title: Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta
Sponsor: W.L.Gore & Associates
PI: Brinkman
Therapeutic Group: Heart Failure
Study Name: TAMBE
Study Title: Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Sponsor: W.L.Gore & Associates
PI: Shutze
Therapeutic Group: Electrophysiology
Study Name: Pivotal TBE (Gore)
Study Title: Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (SSB 11-02)
Sponsor: W.L.Gore & Associates
PI: Brinkman
Therapeutic Group: Cardiology
Study Name: Envision
Study Title: Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients who have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement
Sponsor: Abbott Medical Devices
PI: Harrington
Therapeutic Group: Heart Failure
Study Name: Portico Next Generation Approval Study
Study Title: Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Sponsor: Abbott Medical Devices
PI: Szerlip/Harrington
Therapeutic Group: Heart Failure
Study Name: Symphony-PE
Study Title: Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
Sponsor: Truvic
PI: Sayfo
Therapeutic Group: Heart Failure
Study Name: EARLY TAVR
Study Title: Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients with AsYmptomatic Severe Aortic Stenosis (Protocol Number: 2016-07)
Sponsor: Edwards Lifesciences
PI: Szerlip/Mixon
Therapeutic Group: Heart Failure
Study Name: FASTR
Study Title: Fluid management of Acute decompensated heart failure Subjects Treated with Reprieve Decongestion Management System (DMS) – FASTR Trial
Sponsor: Reprieve Cardiovascular, Inc.
PI: Afzal/Gottlieb
Therapeutic Group: Electrophysiology
Study Name: FASTR II
Study Title: Fluid management of Acute decompensated heart failure Subjects Treated with Reprieve System – FASTR II Trial
Sponsor: Reprieve Cardiovascular, Inc.
PI: Gottlieb
Therapeutic Group: Mitral Valve
Study Name: FORWARD PAD IDE
Study Title: Forward-Shifted Intravascular Lithotripsy (IVL) Technology in a Prospective, Multi-center, Single-arm Investigational Device Exemption (IDE) Study (FORWARD PAD IDE Study)
Sponsor: Shockwave Medical, Inc.
PI: Sayfo
Therapeutic Group: Cardiology
Study Name: Frailty Registry
Study Title: Frailty in advanced heart failure patients
Sponsor: Baylor Scott & White Research Institute
PI: Hsi
Therapeutic Group: Vascular
Study Name: SPYRAL ON
Study Title: Global Clinical Study of Renal Denervation with the Symplicity Spyral multi-electrode renal denervation system in Patients with uncontrolled Hypertentsion on Standard Medical Therapy.
Sponsor: Medtronic Vascular
PI: Choi
Therapeutic Group: Cardiology
Study Name: SPYRAL GEMINI
Study Title: Global pilot study of rEnal and hepatic coMbINed denervatIon in subjects with Uncontrolled Hypertension with and without High Cardiovascular Risk
Sponsor: Medtronic Vascular
PI: Stoler
Therapeutic Group: Heart Failure
Study Name: GREAT
Study Title: Global Registry for Endovascular Aortic Treatment
Sponsor: W.L.Gore & Associates
PI: Gable
Therapeutic Group: Cardiovascular Surgery
Study Name: GUARDIAN
Study Title: Global Utilization And Registry Database for Improved Heart Preservation (GUARDIAN)
Sponsor: Paragonix
PI: Meyer
Therapeutic Group: Cardiology
Study Name: REDUCE PAS
Study Title: GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): The REDUCE Post Approval Study
Sponsor: W.L.Gore & Associates
PI: Widmer
Therapeutic Group: Cardiovascular Surgery
Study Name: TAMBE-PAS
Study Title: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
Sponsor: W.L. Gore & Associates
PI: Eidt
Therapeutic Group: Cardiovascular Surgery
Study Name: IMPROVE
Study Title: IMPact on Revascularization Outcomes of intraVasuclar utltrasound guided treatment of complex lesions and Economic impact (IMPROVE)
Sponsor: MedStar Cardiovascular Research Network
PI: Al-Azizi
Therapeutic Group: Cardiology
Study Name: IMPACT
Study Title: IMpella(R)-Protected cArdiaC surgery Trial (IMPACT) VV-TMF-20447
Sponsor: Abiomed
PI: George
Therapeutic Group: Heart Failure
Study Name: PROTECT-IV
Study Title: Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Sponsor: Abiomed
PI: Sayfo/Kedora
Therapeutic Group: Cardiology
Study Name: IMPROVE-AD
Study Title: IMPRoving Outcomes in Vascular DisEase- Aortic Dissection (IMPROVE-AD)
Sponsor: Duke University
PI: Eidt/Gable
Therapeutic Group: Cardiovascular Surgery
Study Name: INTERMACS
Study Title: Intermacs (Interagency Registry for Mechanically Assisted Circulatory Support)
Sponsor: —
PI: Meyer/Gohar
Therapeutic Group: Electrophysiology
Study Name: INTERCEPT-UK
Study Title: INTERvention with Cerebral Embolic Protection in TEVAR (InterCEPT): Carbon-Dioxide Flushing versus Saline Flushing of Thoracic Aortic Stents: A Multi-centre Randomised Controlled Trial
Sponsor: Imperial College UK
PI: Gable
Therapeutic Group: Cardiovascular Surgery
Study Name: ICE TEE
Study Title: Intracardiac versus transesophageal echocardiographic guidance for left atrial appendage occlusion: Design and rationale of the ICE TEE trial
Sponsor: CVRRC
PI: Al-Azizi
Therapeutic Group: Aortic Valve
Study Name: Shockwave ILIT
Study Title: Intravascular Lithotripsy in high risk calcified Iliac anatomy for Transfemoral TAVR
Sponsor: Investigator Initiated/Grant from Shockwave
PI: Al-Azizi
Therapeutic Group: Cardiology
Study Name: INNOVATE
Study Title: Investigation of a Novel, magNetically levitated VAD for the treatment of refractOry left Ventricular heArT failurE
Sponsor: BrioHealth
PI: Guerrero Miranda
Therapeutic Group: Mitral Valve
Study Name: LeAAPS
Study Title: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial (LeAAPS Trial)
Sponsor: AtriCure, Inc.
PI: Hutcheson/Krueger
Therapeutic Group: Cardiology
Study Name: LAA Ligation
Study Title: Left Atrial Appendage Ligation Prospective
Sponsor: CVRRC
PI: Hutcheson
Therapeutic Group: Cardiovascular Surgery
Study Name: LONG TERM LMCA
Study Title: Long Term Safety and Efficacy of Percutaneous Coronary Artery Intervention for Unprotected Left Main Coronary Artery Disease: the BHVH experience
Sponsor: BHCS Foundation
PI: Choi
Therapeutic Group: Heart Failure
Study Name: TGR 23-02TA
Study Title: Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System Performance
Sponsor: W.L.Gore & Associates
PI: Gable
Therapeutic Group: Aortic Valve
Study Name: LOQI Impella Registry
Study Title: Long-Term Outcome and Quality Indicator (LOQI) Impella Registry
Sponsor: Abiomed
PI: Guerrero Miranda/Afzal
Therapeutic Group: Tricuspid
Explore our research initiatives
Driving the field of cardiovascular care forward
Previous
Next